{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:53:25Z","timestamp":1791381205704,"version":"4.3.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["U54 CA189205"],"award-info":[{"award-number":["U54 CA189205"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["U24 CA224370"],"award-info":[{"award-number":["U24 CA224370"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["U24 TR002278"],"award-info":[{"award-number":["U24 TR002278"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mamm Genome"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00335-019-09809-0","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T05:31:15Z","timestamp":1562218275000},"page":"192-200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Exploring the dark genome: implications for precision medicine"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6195-6976","authenticated-orcid":false,"given":"Tudor I.","family":"Oprea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,4]]},"reference":[{"issue":"4","key":"9809_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/imm.12284","volume":"142","author":"WM Abbott","year":"2014","unstructured":"Abbott WM, Damschroder MM, Lowe DC (2014) Current approaches to fine mapping of antigen-antibody interactions. Immunology 142(4):526\u2013535","journal-title":"Immunology"},{"issue":"2","key":"9809_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/ng1161","volume":"34","author":"M Abifadel","year":"2003","unstructured":"Abifadel M, Varret M, Rab\u00e8s J-P, Allard D, Ouguerram K, Devillers M, Cruaud C et al (2003) Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 34(2):154\u2013156","journal-title":"Nat Genet"},{"key":"9809_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/nar\/gkn665","volume":"37","author":"J Amberger","year":"2009","unstructured":"Amberger J, Bocchini CA, Scott AF, Hamosh A (2009) McKusick\u2019s Online mendelian inheritance in man (OMIM). Nucleic Acids Res 37:793\u2013796","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"9809_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cub.2017.11.064","volume":"28","author":"AL Anding","year":"2018","unstructured":"Anding AL, Wang C, Chang T-K, Sliter DA, Powers CM, Hofmann K, Youle RJ, Baehrecke EH (2018) Vps13D encodes a ubiquitin-binding protein that is required for the regulation of mitochondrial size and clearance. Curr Biol 28(2):287\u2013295","journal-title":"Curr Biol"},{"issue":"1","key":"9809_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler JH, Cherry M, Davis AP et al (2000) Gene ontology: tool for the unification of biology. Nat Genet 25(1):25\u201329","journal-title":"Nat Genet"},{"issue":"February","key":"9809_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fbioe.2019.00021","volume":"7","author":"KM Berger","year":"2019","unstructured":"Berger KM, Schneck PA (2019) National and transnational security implications of asymmetric access to and use of biological data. Front Bioeng Biotechnol 7(February):21","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"9809_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28(1):235\u2013242","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"9809_CR8","doi-asserted-by":"publisher","first-page":"e11732","DOI":"10.2196\/11732","volume":"21","author":"T Bezemer","year":"2019","unstructured":"Bezemer T, de Groot MC, Blasse E, Ten Berg MJ, Kappen TH, Bredenoord AL, van Solinge WW, Hoefer IE, Haitjema S (2019) A human(e) factor in clinical decision support systems. J Med Internet Res 21(3):e11732","journal-title":"J Med Internet Res"},{"key":"9809_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btx200","author":"DC Cannon","year":"2017","unstructured":"Cannon DC, Yang JJ, Mathias SL, Ursu O, Mani S, Waller A, Sch\u00fcrer SC et al (2017) TIN-X: target importance and novelty explorer. Bioinformatics. \n                    https:\/\/doi.org\/10.1093\/bioinformatics\/btx200","journal-title":"Bioinformatics"},{"issue":"9\u201310","key":"9809_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.drudis.2012.11.006","volume":"18","author":"N Clementi","year":"2013","unstructured":"Clementi N, Mancini N, Castelli M, Clementi M, Burioni R (2013) Characterization of epitopes recognized by monoclonal antibodies: experimental Approaches supported by freely accessible bioinformatic tools. Drug Discov Today 18(9\u201310):464\u2013471","journal-title":"Drug Discov Today"},{"issue":"9","key":"9809_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","volume":"372","author":"FS Collins","year":"2015","unstructured":"Collins FS, Varmus H (2015) A new initiative on precision medicine. N Engl J Med 372(9):793\u2013795","journal-title":"N Engl J Med"},{"issue":"11","key":"9809_CR12","doi-asserted-by":"publisher","first-page":"e80491","DOI":"10.1371\/journal.pone.0080491","volume":"8","author":"J Dolan","year":"2013","unstructured":"Dolan J, Mitchell KJ (2013) Mutation of Elfn1 in mice causes seizures and hyperactivity. PLoS ONE 8(11):e80491","journal-title":"PLoS ONE"},{"issue":"7333","key":"9809_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/470163a","volume":"470","author":"AM Edwards","year":"2011","unstructured":"Edwards AM, Isserlin R, Bader GD, Frye SV, Willson TM, Frank HY (2011) Too many roads not taken. Nature 470(7333):163\u2013165","journal-title":"Nature"},{"issue":"D1","key":"9809_CR14","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","volume":"45","author":"A Gaulton","year":"2017","unstructured":"Gaulton A, H A, Nowotka AM, Bento P, Chambers J, Mendez D, Mutowo P et al (2017) The ChEMBL database in 2017. Nucleic Acids Res 45(D1):D945\u2013D954","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"9809_CR15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/ana.25204","volume":"83","author":"J Gauthier","year":"2018","unstructured":"Gauthier J, Meijer IA, Lessel D, Mencacci NE, Krainc D, Hempel M, Tsiakas K et al (2018) Recessive mutations in\u2009>\u2009VPS13D cause childhood onset movement disorders. Ann Neurol 83(6):1089\u20131095","journal-title":"Ann Neurol"},{"issue":"23\u201324","key":"9809_CR16","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/S1359-6446(05)03624-X","volume":"10","author":"PJ Hajduk","year":"2005","unstructured":"Hajduk PJ, Huth JR, Tse C (2005) Predicting protein druggability. Drug Discov Today 10(23\u201324):1675\u20131682","journal-title":"Drug Discov Today"},{"issue":"9","key":"9809_CR17","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd892","volume":"1","author":"AL Hopkins","year":"2002","unstructured":"Hopkins AL, Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1(9):727\u2013730","journal-title":"Nat Rev Drug Discov"},{"issue":"December","key":"9809_CR18","first-page":"366","volume":"6","author":"G Kandoi","year":"2015","unstructured":"Kandoi G, Acencio ML, Lemke N (2015) Prediction of druggable proteins using machine learning and systems biology: a mini-review. Front Physiol 6(December):366","journal-title":"Front Physiol"},{"key":"9809_CR19","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/nar\/gku1011","volume":"43","author":"WA Kibbe","year":"2015","unstructured":"Kibbe WA, Arze C, Felix V, Mitraka E, Bolton E, Fu G, Mungall CJ et al (2015) Disease ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data. Nucleic Acids Res 43:1071\u20131078","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"9809_CR20","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nmeth1008-860","volume":"5","author":"V Kiermer","year":"2008","unstructured":"Kiermer V (2008) Antibodypedia. Nat Methods 5(10):860\u2013861","journal-title":"Nat Methods"},{"issue":"1","key":"9809_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrd986","volume":"2","author":"J Knowles","year":"2003","unstructured":"Knowles J, Gromo Gianni (2003) Target Selection in drug discovery. Nat Rev Drug Discov 2(1):63\u201369","journal-title":"Nat Rev Drug Discov"},{"key":"9809_CR22","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/nar\/gkt977","volume":"42","author":"G Koscielny","year":"2014","unstructured":"Koscielny G, Yaikhom G, Iyer V, Meehan TF, Morgan H, Atienza-Herrero J et al (2014) The international mouse phenotyping consortium web portal, a unified point of access for knockout mice and related phenotyping data. Nucleic Acids Res 42:802\u2013809","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"9809_CR23","doi-asserted-by":"publisher","first-page":"D985","DOI":"10.1093\/nar\/gkw1055","volume":"45","author":"G Koscielny","year":"2017","unstructured":"Koscielny G, An P, Carvalho-Silva D, Cham JA, Fumis L, Gasparyan R, Hasan S et al (2017) Open targets: a platform for therapeutic target identification and validation. Nucleic Acids Res 45(D1):D985\u2013D994","journal-title":"Nucleic Acids Res"},{"key":"9809_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0004-3702(91)90055-O","volume":"47","author":"DB Lenat","year":"1991","unstructured":"Lenat DB, Feigenbaum EA (1991) On the thresholds of knowledge. Artif Intell 47:185\u2013250","journal-title":"Artif Intell"},{"issue":"1","key":"9809_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13326-017-0161-x","volume":"8","author":"Y Lin","year":"2017","unstructured":"Lin Y, M S, K\u00fc\u00e7\u00fck-McGinty H, Turner JP, Vidovic D, Forlin M, Koleti A et al (2017) Drug target ontology to classify and integrate drug discovery data. J Biomed Semant 8(1):50","journal-title":"J Biomed Semant"},{"issue":"1\u20133","key":"9809_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23(1\u20133):3\u201325","journal-title":"Adv Drug Deliv Rev"},{"issue":"D1","key":"9809_CR27","doi-asserted-by":"publisher","first-page":"D896","DOI":"10.1093\/nar\/gkw1133","volume":"45","author":"J MacArthur","year":"2017","unstructured":"MacArthur J, Bowler E, Cerezo M, Gil L, Hall P, Hastings E, Junkins H et al (2017) The new NHGRI-EBI catalog of published genome-Wide association studies (GWAS Catalog). Nucleic Acids Res 45(D1):D896\u2013D901","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"9809_CR28","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1534\/genetics.116.188870","volume":"203","author":"JA McMurry","year":"2016","unstructured":"McMurry JA, K\u00f6hler S, Washington NL, Balhoff JP, Borromeo C, Brush M, Carbon S et al (2016) Navigating the phenotype frontier: the monarch initiative. Genetics 203(4):1491\u20131495","journal-title":"Genetics"},{"issue":"4","key":"9809_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40259-016-0181-6","volume":"30","author":"DR Mould","year":"2016","unstructured":"Mould DR, Meibohm B (2016) Drug development of therapeutic monoclonal antibodies. BioDrugs 30(4):275\u2013293","journal-title":"BioDrugs"},{"key":"9809_CR30","volume-title":"Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease","author":"National Research Council, Division on Earth and Life Studies, Board on Life Sciences, and Committee on A Framework for Developing a New Taxonomy of Disease","year":"2012","unstructured":"National Research Council, Division on Earth and Life Studies, Board on Life Sciences, and Committee on A Framework for Developing a New Taxonomy of Disease (2012) Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. National Academies Press, Washington DC"},{"issue":"D1","key":"9809_CR31","doi-asserted-by":"publisher","first-page":"D995","DOI":"10.1093\/nar\/gkw1072","volume":"45","author":"D-T Nguyen","year":"2017","unstructured":"Nguyen D-T, Mathias S, Bologa C, Brunak S, Fernandez N, Gaulton A, Hersey A et al (2017) Pharos: collating protein information to shed light on the druggable genome. Nucleic Acids Res 45(D1):D995\u2013D1002","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"9809_CR32","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1093\/emboj\/cdg359","volume":"22","author":"IMA Nooren","year":"2003","unstructured":"Nooren IMA, Thornton JM (2003) Diversity of protein\u2013protein interactions. EMBO J 22(14):3486\u20133492","journal-title":"EMBO J"},{"issue":"5","key":"9809_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nrd.2018.52","volume":"17","author":"TI Oprea","year":"2018","unstructured":"Oprea TI, Bologa CG, Brunak S, Campbell A, Gan GN, Gaulton A, Gomez SM et al (2018a) Unexplored therapeutic opportunities in the human genome. Nat Rev Drug Discov 17(5):377","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"9809_CR34","doi-asserted-by":"publisher","first-page":"e3000067","DOI":"10.1371\/journal.pbio.3000067","volume":"16","author":"TI Oprea","year":"2018","unstructured":"Oprea TI, Jan L, Johnson GL, Roth BL, Ma\u2019ayan A A, Sch\u00fcrer S, Shoichet BK, Sklar LA, McManus MT (2018b) Far away from the lamppost. PLoS Biol 16(12):e3000067","journal-title":"PLoS Biol"},{"issue":"6","key":"9809_CR35","doi-asserted-by":"publisher","first-page":"e65390","DOI":"10.1371\/journal.pone.0065390","volume":"8","author":"E Pafilis","year":"2013","unstructured":"Pafilis E, Frankild SP, Fanini L, Faulwetter S, Pavloudi C, Vasileiadou A, Arvanitidis C, Jensen LJ (2013) The SPECIES and ORGANISMS resources for fast and accurate identification of taxonomic names in text. PLoS ONE 8(6):e65390","journal-title":"PLoS ONE"},{"issue":"2","key":"9809_CR36","doi-asserted-by":"publisher","first-page":"e88889","DOI":"10.1371\/journal.pone.0088889","volume":"9","author":"AK Pandey","year":"2014","unstructured":"Pandey AK, Lu L, Wang X, Homayouni R, Williams RW (2014) Functionally enigmatic genes: a case study of the brain ignorome. PLoS ONE 9(2):e88889","journal-title":"PLoS ONE"},{"issue":"1","key":"9809_CR37","first-page":"170","volume":"2016","author":"RL Perlman","year":"2016","unstructured":"Perlman RL (2016) Mouse models of human disease: an evolutionary perspective. Evol Med Public Health 2016(1):170\u2013176","journal-title":"Evol Med Public Health"},{"issue":"March","key":"9809_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ymeth.2014.11.020","volume":"74","author":"S Pletscher-Frankild","year":"2015","unstructured":"Pletscher-Frankild S, Pallej\u00e0 A, Tsafou K, Binder JX, Jensen LJ (2015) DISEASES: text Mining and data integration of disease-gene associations. Methods 74(March):83\u201389","journal-title":"Methods"},{"issue":"4","key":"9809_CR39","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1074\/jbc.M708098200","volume":"283","author":"S Poirier","year":"2008","unstructured":"Poirier S, Mayer G, Benjannet S, Bergeron E, Marcinkiewicz J, Nassoury N, Mayer H, Nimpf J, Prat A, Seidah NG (2008) The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2. J Biol Chem 283(4):2363\u20132372","journal-title":"J Biol Chem"},{"issue":"1","key":"9809_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12911-018-0719-2","volume":"18","author":"M Prosperi","year":"2018","unstructured":"Prosperi M, Min JS, Bian J, Modave F (2018) Big data hurdles in precision medicine and precision public health. BMC Med Inf Decis Mak 18(1):139","journal-title":"BMC Med Inf Decis Mak"},{"issue":"12","key":"9809_CR41","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1172\/JCI200318925","volume":"111","author":"DJ Rader","year":"2003","unstructured":"Rader DJ, Cohen J, Hobbs HH (2003) Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Investig 111(12):1795\u20131803","journal-title":"J Clin Investig"},{"issue":"5","key":"9809_CR42","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/humu.22078","volume":"33","author":"A Rath","year":"2012","unstructured":"Rath A, Olry A, Dhombres F, Brandt MM, Urbero B, Ayme S (2012) Representation of rare diseases in health information systems: the orphanet approach to serve a wide range of end users. Hum Mutat 33(5):803\u2013808","journal-title":"Hum Mutat"},{"issue":"1","key":"9809_CR43","doi-asserted-by":"publisher","first-page":"a000372","DOI":"10.1101\/mcs.a000372","volume":"1","author":"PN Robinson","year":"2015","unstructured":"Robinson PN, Mungall CJ, Haendel M (2015) Capturing phenotypes for precision medicine. Cold Spring Harb Mol Case Stud 1(1):a000372","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"5","key":"9809_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrd.2017.252","volume":"17","author":"G Rodgers","year":"2018","unstructured":"Rodgers G, Austin C, Anderson J, Pawlyk A, Colvis C, Margolis R, Baker J (2018) Glimmers in illuminating the druggable genome. Nat Rev Drug Discov 17(5):301\u2013302","journal-title":"Nat Rev Drug Discov"},{"key":"9809_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baw100","author":"AD Rouillard","year":"2016","unstructured":"Rouillard AD, Gundersen GW, Fernandez NF, Wang Z, Monteiro CD, McDermott MG, Ma\u2019ayan A (2016) The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database. \n                    https:\/\/doi.org\/10.1093\/database\/baw100","journal-title":"Database"},{"issue":"2","key":"9809_CR46","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1194\/jlr.R039297","volume":"55","author":"K-A Rye","year":"2014","unstructured":"Rye K-A, Barter PJ (2014) Cardioprotective functions of HDLs. J Lipid Res 55(2):168\u2013179","journal-title":"J Lipid Res"},{"issue":"1","key":"9809_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrd.2016.230","volume":"16","author":"R Santos","year":"2017","unstructured":"Santos R, Ursu O, Gaulton A, Bento AP, Donadi RS, Bologa CG, Karlsson A et al (2017) A comprehensive map of molecular drug targets. Nat Rev Drug Discov 16(1):19\u201334","journal-title":"Nat Rev Drug Discov"},{"key":"9809_CR48","first-page":"439","volume":"24","author":"MG Seneviratne","year":"2019","unstructured":"Seneviratne MG, Kahn MG, Hernandez-Boussard T (2019) Merging heterogeneous clinical data to enable knowledge discovery. Pac Symp Biocomput 24:439\u2013443","journal-title":"Pac Symp Biocomput"},{"issue":"6","key":"9809_CR49","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/ana.25220","volume":"83","author":"E Seong","year":"2018","unstructured":"Seong E, Insolera R, Dulovic M, Kamsteeg E-J, Trinh J, Br\u00fcggemann N, Sandford E et al (2018) Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects. Ann Neurol 83(6):1075\u20131088","journal-title":"Ann Neurol"},{"issue":"May","key":"9809_CR50","doi-asserted-by":"publisher","first-page":"15606","DOI":"10.1038\/ncomms15606","volume":"8","author":"L Southam","year":"2017","unstructured":"Southam L, Gilly A, S\u00fcveges D, Farmaki A-E, Schwartzentruber J, Tachmazidou I, Matchan A et al (2017) Whole genome sequencing and imputation in isolated populations identify genetic associations with medically-relevant complex traits. Nat Commun 8(May):15606","journal-title":"Nat Commun"},{"issue":"D1","key":"9809_CR51","doi-asserted-by":"publisher","first-page":"D1054","DOI":"10.1093\/nar\/gkv1037","volume":"44","author":"C Southan","year":"2016","unstructured":"Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SPH, Buneman OP et al (2016) The IUPHAR\/BPS guide to pharmacology in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res 44(D1):D1054\u2013D1068","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"9809_CR52","doi-asserted-by":"publisher","first-page":"e2006643","DOI":"10.1371\/journal.pbio.2006643","volume":"16","author":"T Stoeger","year":"2018","unstructured":"Stoeger T, Gerlach M, Morimoto RI, Amaral LAN (2018) Large-scale investigation of the reasons why potentially important genes are ignored. PLoS Biol 16(9):e2006643","journal-title":"PLoS Biol"},{"issue":"10","key":"9809_CR53","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa063842","volume":"355","author":"G Suntharalingam","year":"2006","unstructured":"Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, Panoskaltsis N (2006) Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355(10):1018\u20131028","journal-title":"N Engl J Med"},{"issue":"1","key":"9809_CR54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.chembiol.2011.12.013","volume":"19","author":"S Surade","year":"2012","unstructured":"Surade S, Blundell TL (2012) Structural biology and drug discovery of difficult targets: the limits of ligandability. Chem Biol 19(1):42\u201350","journal-title":"Chem Biol"},{"issue":"D1","key":"9809_CR55","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M et al (2019) STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607\u2013D613","journal-title":"Nucleic Acids Res"},{"key":"9809_CR56","unstructured":"Target importance and novelty explorer (TIN-X) (2014) TIN-X. \n                    http:\/\/newdrugtargets.org\/\n                    \n                  . Accessed 14 Dec 2014"},{"issue":"July","key":"9809_CR57","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1038\/ncomms5501","volume":"5","author":"NH Tomioka","year":"2014","unstructured":"Tomioka NH, Yasuda H, Miyamoto H, Hatayama M, Morimura N, Matsumoto Y, Suzuki T et al (2014) Elfn1 recruits presynaptic mGluR7 in trans and its loss results in seizures. Nat Commun 5(July):4501","journal-title":"Nat Commun"},{"key":"9809_CR58","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/nar\/gku989","volume":"43","author":"UniProt Consortium","year":"2015","unstructured":"UniProt Consortium (2015) UniProt: a hub for protein information. Nucleic Acids Res 43:204\u2013212","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"9809_CR59","doi-asserted-by":"publisher","first-page":"D932","DOI":"10.1093\/nar\/gkw993","volume":"45","author":"O Ursu","year":"2017","unstructured":"Ursu O, Holmes J, Knockel J, Bologa CG, Yang JJ, Mathias SL, Nelson SJ, Oprea TI (2017) DrugCentral: online drug compendium. Nucleic Acids Res 45(D1):D932\u2013D939","journal-title":"Nucleic Acids Res"},{"key":"9809_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-019-00052-5","author":"O Ursu","year":"2019","unstructured":"Ursu O, Glick M, Oprea T (2019a) Novel drug targets in 2018. Nat Rev Drug Discov. \n                    https:\/\/doi.org\/10.1038\/d41573-019-00052-5","journal-title":"Nat Rev Drug Discov"},{"issue":"D1","key":"9809_CR61","doi-asserted-by":"publisher","first-page":"D963","DOI":"10.1093\/nar\/gky963","volume":"47","author":"O Ursu","year":"2019","unstructured":"Ursu O, Holmes J, Bologa CG, Yang JJ, Mathias SL, Stathias V, Nguyen D-T, Sch\u00fcrer S, Oprea T (2019b) DrugCentral 2018: an update. Nucleic Acids Res 47(D1):D963\u2013D970","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"9809_CR62","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/CIRCRESAHA.117.312086","volume":"122","author":"P van der Harst","year":"2018","unstructured":"van der Harst P, Verweij N (2018) Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circ Res 122(3):433\u2013443","journal-title":"Circ Res"},{"issue":"3","key":"9809_CR63","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ygeno.2004.04.012","volume":"84","author":"A Velayos-Baeza","year":"2004","unstructured":"Velayos-Baeza A, Vettori A, Copley RR, Dobson-Stone C, Monaco AP (2004) Analysis of the human VPS13 gene family. Genomics 84(3):536\u2013549","journal-title":"Genomics"},{"issue":"13","key":"9809_CR64","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1093\/bioinformatics\/btx120","volume":"33","author":"Watkins, X, Garcia LJ, Pundir S, Martin MJ, UniProt Consortium","year":"2017","unstructured":"Watkins, X, Garcia LJ, Pundir S, Martin MJ, UniProt Consortium (2017) ProtVista: visualization of protein sequence annotations. Bioinformatics 33(13):2040\u20132041","journal-title":"Bioinformatics"},{"issue":"3","key":"9809_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.117.006428","volume":"7","author":"MT Woon","year":"2018","unstructured":"Woon MT, Long PA, Reilly L, Evans JM, Keefe AM, Lea MR, Beglinger CJ et al (2018) Pediatric dilated cardiomyopathy-associated LRRC10 (Leucine-rich repeat-containing 10) variant reveals LRRC10 as an auxiliary subunit of cardiac L-type Ca2 + channels. J Am Heart Assoc 7(3):1\u201310. \n                    https:\/\/doi.org\/10.1161\/JAHA.117.006428","journal-title":"J Am Heart Assoc"},{"issue":"November","key":"9809_CR66","doi-asserted-by":"publisher","first-page":"36626","DOI":"10.1038\/srep36626","volume":"6","author":"Fan Wu","year":"2016","unstructured":"Wu Fan, Ma Cong, Tan Cheemeng (2016) Network motifs modulate druggability of cellular targets. Sci Rep 6(November):36626","journal-title":"Sci Rep"}],"container-title":["Mammalian Genome"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-019-09809-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00335-019-09809-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-019-09809-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T23:16:25Z","timestamp":1593731785000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00335-019-09809-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,4]]},"references-count":66,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["9809"],"URL":"https:\/\/doi.org\/10.1007\/s00335-019-09809-0","relation":{},"ISSN":["0938-8990","1432-1777"],"issn-type":[{"value":"0938-8990","type":"print"},{"value":"1432-1777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,4]]},"assertion":[{"value":"23 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Oprea was a former full-time employee at AstraZeneca (1996\u20132002). He has received honoraria, or consulted for, Abbott, AstraZeneca, Chiron, Genentech, Infinity Pharmaceuticals, Merz Pharmaceuticals, Merck Darmstadt, Mitsubishi Tanabe, Novartis, Ono Pharmaceuticals, Pfizer, Roche, Sanofi, and Wyeth. His spouse was a full-time employee of AstraZeneca (2002\u20132014) and is a full-time employee of Genentech Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}